Cargando…

Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease

The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has no publicly available vaccine or antiviral drugs at the time of writing. An attractive coronavirus drug target is the main protease (M(pro), also known as 3CL(pro)) because of its vital role in the viral cycle. A significant body o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubanevics, Igors, McLeish, Tom C. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879766/
https://www.ncbi.nlm.nih.gov/pubmed/33402024
http://dx.doi.org/10.1098/rsif.2020.0591
_version_ 1783650576362373120
author Dubanevics, Igors
McLeish, Tom C. B.
author_facet Dubanevics, Igors
McLeish, Tom C. B.
author_sort Dubanevics, Igors
collection PubMed
description The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has no publicly available vaccine or antiviral drugs at the time of writing. An attractive coronavirus drug target is the main protease (M(pro), also known as 3CL(pro)) because of its vital role in the viral cycle. A significant body of work has been focused on finding inhibitors which bind and block the active site of the main protease, but little has been done to address potential non-competitive inhibition, targeting regions other than the active site, partly because the fundamental biophysics of such allosteric control is still poorly understood. In this work, we construct an elastic network model (ENM) of the SARS-CoV-2 M(pro) homodimer protein and analyse its dynamics and thermodynamics. We found a rich and heterogeneous dynamical structure, including allosterically correlated motions between the homodimeric protease's active sites. Exhaustive 1-point and 2-point mutation scans of the ENM and their effect on fluctuation free energies confirm previously experimentally identified bioactive residues, but also suggest several new candidate regions that are distant from the active site, yet control the protease function. Our results suggest new dynamically driven control regions as possible candidates for non-competitive inhibiting binding sites in the protease, which may assist the development of current fragment-based binding screens. The results also provide new insights into the active biophysical research field of protein fluctuation allostery and its underpinning dynamical structure.
format Online
Article
Text
id pubmed-7879766
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society
record_format MEDLINE/PubMed
spelling pubmed-78797662021-02-12 Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease Dubanevics, Igors McLeish, Tom C. B. J R Soc Interface Life Sciences–Physics interface The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has no publicly available vaccine or antiviral drugs at the time of writing. An attractive coronavirus drug target is the main protease (M(pro), also known as 3CL(pro)) because of its vital role in the viral cycle. A significant body of work has been focused on finding inhibitors which bind and block the active site of the main protease, but little has been done to address potential non-competitive inhibition, targeting regions other than the active site, partly because the fundamental biophysics of such allosteric control is still poorly understood. In this work, we construct an elastic network model (ENM) of the SARS-CoV-2 M(pro) homodimer protein and analyse its dynamics and thermodynamics. We found a rich and heterogeneous dynamical structure, including allosterically correlated motions between the homodimeric protease's active sites. Exhaustive 1-point and 2-point mutation scans of the ENM and their effect on fluctuation free energies confirm previously experimentally identified bioactive residues, but also suggest several new candidate regions that are distant from the active site, yet control the protease function. Our results suggest new dynamically driven control regions as possible candidates for non-competitive inhibiting binding sites in the protease, which may assist the development of current fragment-based binding screens. The results also provide new insights into the active biophysical research field of protein fluctuation allostery and its underpinning dynamical structure. The Royal Society 2021-01 2021-01-06 /pmc/articles/PMC7879766/ /pubmed/33402024 http://dx.doi.org/10.1098/rsif.2020.0591 Text en © 2021 The Authors. http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/http://creativecommons.org/licenses/by/4.0/Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.
spellingShingle Life Sciences–Physics interface
Dubanevics, Igors
McLeish, Tom C. B.
Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease
title Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease
title_full Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease
title_fullStr Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease
title_full_unstemmed Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease
title_short Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease
title_sort computational analysis of dynamic allostery and control in the sars-cov-2 main protease
topic Life Sciences–Physics interface
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879766/
https://www.ncbi.nlm.nih.gov/pubmed/33402024
http://dx.doi.org/10.1098/rsif.2020.0591
work_keys_str_mv AT dubanevicsigors computationalanalysisofdynamicallosteryandcontrolinthesarscov2mainprotease
AT mcleishtomcb computationalanalysisofdynamicallosteryandcontrolinthesarscov2mainprotease